TSE:CRDL

Cardiol Therapeutics (CRDL) Stock Price, News & Analysis

Cardiol Therapeutics logo
C$1.22 -0.03 (-2.40%)
As of 11/20/2026 04:00 PM Eastern

About Cardiol Therapeutics Stock (TSE:CRDL)

Advanced

Key Stats

Today's Range
C$1.22
▼
C$1.28
50-Day Range
C$1.22
▼
C$2.77
52-Week Range
C$1.22
▼
C$3.23
Volume
85,564 shs
Average Volume
138,651 shs
Market Capitalization
C$155.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cardiol Therapeutics Inc. ( NASDAQ: CRDL ) ( TSX: CRDL ) is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. The Company's lead small-molecule drug candidate, CardiolRx¿, modulates inflammasome pathway activation, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with pericarditis, myocarditis, and heart failure. The MAVERIC Program is evaluating CardiolRx¿ for the treatment of recurrent pericarditis, an inflammatory disease of the pericardium associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, which can lead to physical limitations, reduced quality of life, emergency department visits, and hospitalizations. The program comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing pivotal Phase III MAVERIC trial (NCT06708299).

Receive CRDL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRDL Stock News Headlines

Cardiol Therapeutics (TSE:CRDL) Stock Price Down 5.4% - Time to Sell?
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Headlines

CRDL Stock Analysis - Frequently Asked Questions

Cardiol Therapeutics' stock was trading at C$1.31 at the start of the year. Since then, CRDL shares have decreased by 6.9% and is now trading at C$1.22.

Cardiol Therapeutics Inc. (TSE:CRDL) posted its quarterly earnings results on Thursday, November, 12th. The company reported C($0.11) EPS for the quarter.

Shares of CRDL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiol Therapeutics investors own include Gilead Sciences (GILD), Cardiol Therapeutics (CRTPF), Smart Cannabis (SCNA), Air Canada (AC), Teck Resources (TECK.B), Luminar Technologies (LAZR) and Plug Power (PLUG).

Company Calendar

Last Earnings
11/12/2026
Today
11/22/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
TSE:CRDL
CIK
N/A
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$42.93 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-159.80%
Return on Assets
-54.15%

Debt

Debt-to-Equity Ratio
0.35
Current Ratio
6.26
Quick Ratio
6.84

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$1.24 per share
Price / Cash Flow
0.98
Book Value
C$0.23 per share
Price / Book
5.22

Miscellaneous

Outstanding Shares
127,688,000
Free Float
N/A
Market Cap
C$155.78 million
Optionable
Not Optionable
Beta
0.14
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (TSE:CRDL) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners